Original Source(s)
Related Content
Role of Health-Related Discrimination on Academic Performance Among Children with Congenital Heart Disease
by Aliba Syed, Timothy Dixon, Dmitry Tumin, Meredith Sooy-Mossey
September 2, 2026
FDA approves first therapy for warm autoimmune hemolytic anemia
The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.
August 25, 2026
-
3 min